ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,544Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 337

$483K Total Retail Price of All Prescriptions

Rank: 83 out of 337

418 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 7,941 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 490 461 1 2
ATORVASTATIN CALCIUM 480 454 2 7
AMLODIPINE BESYLATE 330 304 3 3
OMEPRAZOLE 314 291 4 4
SIMVASTATIN 311 299 5 1
FUROSEMIDE 302 284 6 8
ATENOLOL 300 291 7 10
LEVOTHYROXINE SODIUM 265 246 8 5
WARFARIN SODIUM 231 201 9 11
CITALOPRAM HBR 176 134 10 17
LOSARTAN POTASSIUM 171 154 11 15
METOPROLOL TARTRATE 156 145 12 6
METFORMIN HCL 151 147 13 12
HYDROCHLOROTHIAZIDE 150 132 14 9
DONEPEZIL HCL 130 130 15 22
METOPROLOL SUCCINATE 126 112 16 21
ADVAIR DISKUS 122 115 17 44
DIOVAN 116 116 18 26
CRESTOR 102 99 19 29
LIPITOR 99 97 20 33
FLUTICASONE PROPIONATE 97 87 21 34
TRAZODONE HCL 95 90 22 16
LANTUS SOLOSTAR 95 83 22 146
ZOLPIDEM TARTRATE 80 71 24 23
METFORMIN HCL ER 78 74 25 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 71 26 31
EVISTA 76 76 27 102
TRAMADOL HCL 71 68 28 32
NAMENDA 67 67 29 35
PROAIR HFA 62 45 30 38
PRAVASTATIN SODIUM 61 55 31 14
SERTRALINE HCL 61 59 31 18
TRIAMTERENE-HCTZ 61 61 31 39
TAMSULOSIN HCL 60 60 34 25
ALENDRONATE SODIUM 60 56 34 19
ESCITALOPRAM OXALATE 57 53 36 66
PANTOPRAZOLE SODIUM 54 47 37 36
MELOXICAM 53 39 38 54
RANITIDINE HCL 53 50 38 30
IBUPROFEN 51 42 40 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.